Loading ...

Stock Quote cytr

cytr Stock Price Today

cytr Price History

cytr Stock Price History

cytr History

Last Price cytr

Close Price cytr

Day Change cytr

After Hours Quote cytr

Open Price cytr

Day Range cytr

Year Range cytr

Projected Yield cytr

Market Cap cytr

Stock Volume cytr

Average Volume cytr

Forward Price cytr

PE for cytr

PB for cytr

PS for cytr

PCF for cytr

price earnings ratio cytr

price to book ratio cytr

price to sales ratio cytr

price to cash flow ratio cytr

Stock Quote CytRx Corp

CytRx Corp Stock Price today

CytRx Corp Price history

CytRx Corp Stock Price history

CytRx Corp history

Last Price CytRx Corp

Close Price CytRx Corp

Day Change CytRx Corp

After Hours Quote for CytRx Corp

Open Price CytRx Corp

Day Range CytRx Corp

Year Range CytRx Corp

Projected Yield CytRx Corp

Market Cap CytRx Corp

Stock Volume CytRx Corp

Average Volume CytRx Corp

Forward Price CytRx Corp

pe CytRx Corp

pb CytRx Corp

ps CytRx Corp

pcf CytRx Corp

price earnings ratio CytRx Corp

price to book ratio CytRx Corp

price to sales ratio CytRx Corp

price to cash flow ratio CytRx Corp

What Does This Company Do?
CytRx Corp is a biopharmaceutical research and development company specializing in oncology. Its oncology pipeline includes three clinical-stage drug candidates in various stages of development: Aldoxorubicin, Tamibarotene, and Bafetinib.
Sector
Healthcare
Industry
Biotechnology
Stock Type
Distressed
Employees
17
Stock Style
Small Growth

Key Stats  CYTR More...

Key Stats CYTR

S&P 500 index data: S&P 500 Copyright ©

All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .

News  cytr - CytRx Corp More...

EQUITY ALERT: Rosen Law Firm Reminds CytRx Corporation Investors of Important May 14, 2014 Deadline in the Class Action Filed by the Firm -- CYTR
Wolf Haldenstein Adler Freeman & Herz LLP Reminds Investors of the May 13, 2014 Deadline to File for Lead Plaintiff in the Securities Fraud Class Action Against CytRx Corporation -- CYTR
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against CytRx Corporation and Certain Officers -- CYTR
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in CytRx Corporation of Class Action Lawsuit and Upcoming Deadline -- CYTR
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against CytRx Corporation and Certain Officers - CYTR
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against CYTRX CORPORATION and Its Board of Directors and a Lead Plaintiff Deadline of May 13, 2014 -- CYTR
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against CYTRX CORPORATION and Its Board of Directors and a Lead Plaintiff Deadline of May 13, 2014 -- CYTR
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in CytRx Corporation to Contact Brower Piven Before the May 13, 2014 Lead Plaintiff Deadline -- CYTR
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in CytRx Corporation to Contact Brower Piven Before the May 13, 2014 Lead Plaintiff Deadline -- CYTR
CYTRX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against CytRx Corporation - CYTR
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Analysis  cytr - CytRx Corp More...

Free Issue - Morningstar's Dividend Newsletter
More...

An investment is only as good as the cash it returns directly to your pockets. That's why Morningstar DividendInvestor's buy and sell recommendations are driven entirely by dividends. Our total-return strategy gives you carefully selected, picks that combine current income and income growth to generate large, reliable and growing cash returns. Click to try!

More reports cytr - CytRx CorpMore...

Click above to view more mutual fund data and stats for cytr - CytRx Corp.

  • Performance
  • Asset Allocation
  • Dividend and Capital Gains Distribution
  • News, Alerts and Opinions
  • Video reports
  • Management
  • Filings

Ownership   CYTR More ...

Ownership CYTR

Vanguard Total Stock Mkt Idx
Franklin Biotechnology Discovery A
Vanguard Extended Market Idx Inv
iShares Russell 2000 Value
Fidelity SpartanĀ® Extended Mkt Index Inv

Wall St. Recommendations  cytr - CytRx Corp More...

Wall Street Analyst Recommendation CYTR

Stock Price Quote: cytr CytRx Corp - XNAS - Morningstar
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry

Previous: cx5n - CytRx Corp  |  Next: cyca - Cytta Corporation